FEATURES OF LOCAL IMMUNITY IN PATIENTS WITH OROPHARYNGEAL CANCER

dc.contributor.author	Nurov Jamshid Raxmatovich
dc.date.accessioned	2025-12-29T17:58:33Z
dc.date.issued	2025-05-12
dc.description.abstract	Cancer of the oral cavity and oropharynx in clinical practice is considered as a single oncopathology, treated as oropharyngeal cancer (OPR). This pathology occupies the 2nd place in the incidence rate among head and neck tumors in the Russian Federation [1]. The incidence of OFR in the Russian Federation is not the same: in the industrial districts, which include the Rostov region, it is high, which put the region in the top ten regions with a high incidence of this pathology.
dc.format	application/pdf
dc.identifier.uri	https://webofjournals.com/index.php/5/article/view/4139
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/24627
dc.language.iso	eng
dc.publisher	Web of Journals Publishing
dc.relation	https://webofjournals.com/index.php/5/article/view/4139/4095
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	Web of Medicine: Journal of Medicine, Practice and Nursing ; Vol. 3 No. 5 (2025): WOM; 129-133
dc.source	2938-3765
dc.title	FEATURES OF LOCAL IMMUNITY IN PATIENTS WITH OROPHARYNGEAL CANCER
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: raxmatovich_2025_features_of_local_immunity_in_patients_w.pdf
item.page.filesection.size: 337 KB
item.page.filesection.format: Adobe Portable Document Format